Eilean Therapeutics
🇺🇸United States
Clinical Study Aiming to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Administration of ZE50-0134 at 5 Dose Levels in Healthy Volunteers
Phase 1
Recruiting
- Conditions
- Healthy
- Interventions
- Drug: ZE50-0134 or placebo
- First Posted Date
- 2025-01-22
- Last Posted Date
- 2025-01-22
- Lead Sponsor
- Eilean Therapeutics
- Target Recruit Count
- 88
- Registration Number
- NCT06787131
- Locations
- 🇦🇺
Scientia Clinical Research, Sydney, Randwick NSW, Australia
Сlinical Study Aiming to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Doses of ZE63-0302 in Healthy Volunteers
Phase 1
Recruiting
- Conditions
- Healthy
- Interventions
- Drug: ZE63-0302 or placebo
- First Posted Date
- 2025-01-17
- Last Posted Date
- 2025-01-17
- Lead Sponsor
- Eilean Therapeutics
- Target Recruit Count
- 88
- Registration Number
- NCT06780124
- Locations
- 🇦🇺
Linear Clinical Research Ltd, Perth, Nedlands, Australia
A Phase 1 Study of ZE50-0134 in Relapsed and Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Select Low-grad Lymphomas
Phase 1
Not yet recruiting
- Conditions
- CLL / SLLCLL (Chronic Lymphocytic Leukemia)SLL (Small Lymphocytic Lymphoma)
- Interventions
- First Posted Date
- 2024-11-27
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Eilean Therapeutics
- Target Recruit Count
- 66
- Registration Number
- NCT06708897
Study of Single and Multiple Ascending Doses of ZE46-0134 in Healthy Volunteers
Phase 1
Recruiting
- Conditions
- AML
- Interventions
- Drug: ZE46-0134 or placeboDrug: Rabeprazole, 20mg oral
- First Posted Date
- 2024-05-03
- Last Posted Date
- 2024-05-03
- Lead Sponsor
- Eilean Therapeutics
- Target Recruit Count
- 64
- Registration Number
- NCT06399315
- Locations
- 🇦🇺
Linear Clinical Research Ltd, Perth, Nedlands, Australia
Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated Relapsed or Refractory Acute Myeloid Leukemia
- First Posted Date
- 2024-04-16
- Last Posted Date
- 2024-04-16
- Lead Sponsor
- Eilean Therapeutics
- Target Recruit Count
- 60
- Registration Number
- NCT06366789
- Locations
- 🇦🇺
Linear Clinical Research Ltd, Perth, Nedlands, WA, Australia
© Copyright 2025. All Rights Reserved by MedPath